Literature DB >> 31779815

Parkinsonism in frontotemporal dementias.

James B Rowe1.   

Abstract

Frontotemporal dementia is a clinically and pathologically heterogeneous group of neurodegenerative disorders, with progressive impairment of behavior and language. They can be closely related to amyotrophic lateral sclerosis, clinically and through shared genetics and similar pathology. Approximately 40% of people with frontotemporal dementia report a family history of dementia, motor neuron disease or parkinsonism, and half of these familial cases are attributed to mutations in three genes (C9orf72, MAPT and PGRN). Akinetic-rigidity is a common feature in several types of frontotemporal dementia, particularly the behavioral variant and the non-fluent agrammatic variant of primary progressive aphasia, and the familial dementias. The majority of patients develop a degree of parkinsonism during the course of the illness, and signs may be present at the time of initial diagnosis. However, the parkinsonism of frontotemporal dementia is very different from that observed in idiopathic Parkinson's disease: it may be symmetric, axial, and poorly responsive to levodopa. Tremor is uncommon, and may be postural, action or occasionally rest tremor. The emergence of parkinsonism is often part of an evolving phenotype, in which frontotemporal dementia comes to resemble corticobasal syndrome or progressive supranuclear palsy. This chapter describes the prevalence and phenomenology of parkinsonism in each of the major syndromes, and according to the common genetic forms of frontotemporal dementia. We discuss the changing nosology and terminology surrounding the diagnoses, and the significance of parkinsonism as a core feature of frontotemporal dementia, relevant to clinical management and the design of future clinical trials.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  C9orf72; Frontotemporal dementia; MAPT; Pick's disease; Primary progressive aphasia; Progranulin

Mesh:

Year:  2019        PMID: 31779815     DOI: 10.1016/bs.irn.2019.10.012

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN: 0074-7742            Impact factor:   3.230


  8 in total

1.  Functional Disabilities and Psychiatric Symptoms in Primary Progressive Aphasia.

Authors:  Christopher B Morrow; Jeannie-Marie Sheppard Leoutsakos; Chiadi U Onyike
Journal:  Am J Geriatr Psychiatry       Date:  2021-07-28       Impact factor: 7.996

Review 2.  Looking beneath the surface: the importance of subcortical structures in frontotemporal dementia.

Authors:  Martina Bocchetta; Maura Malpetti; Emily G Todd; James B Rowe; Jonathan D Rohrer
Journal:  Brain Commun       Date:  2021-07-16

3.  Parkin Levels Decrease in Fibroblasts With Progranulin (PGRN) Pathogenic Variants and in a Cellular Model of PGRN Deficiency.

Authors:  Katarzyna Gaweda-Walerych; Dawid Walerych; Mariusz Berdyński; Emanuele Buratti; Cezary Zekanowski
Journal:  Front Mol Neurosci       Date:  2021-05-13       Impact factor: 5.639

4.  Neurocognitive health of older adults experiencing homelessness in Oakland, California.

Authors:  Sandeepa Satya-Sriram Mullady; Stacy Castellanos; Lucia Lopez; Gloria Aguirre; John Weeks; Stephen King; Karen Valle; Collette Goode; Elena Tsoy; Katherine Possin; Bruce Miller; Margot Kushel; Serggio Lanata
Journal:  Front Neurol       Date:  2022-07-22       Impact factor: 4.086

5.  Utility of the Addenbrooke's Cognitive Examination III online calculator to differentiate the primary progressive aphasia variants.

Authors:  D Foxe; A Hu; S C Cheung; R M Ahmed; N J Cordato; E Devenney; Y T Hwang; G M Halliday; N Mueller; C E Leyton; J R Hodges; J R Burrell; M Irish; O Piguet
Journal:  Brain Commun       Date:  2022-07-07

6.  Apathy in presymptomatic genetic frontotemporal dementia predicts cognitive decline and is driven by structural brain changes.

Authors:  Maura Malpetti; P Simon Jones; Kamen A Tsvetanov; Timothy Rittman; John C van Swieten; Barbara Borroni; Raquel Sanchez-Valle; Fermin Moreno; Robert Laforce; Caroline Graff; Matthis Synofzik; Daniela Galimberti; Mario Masellis; Maria Carmela Tartaglia; Elizabeth Finger; Rik Vandenberghe; Alexandre de Mendonça; Fabrizio Tagliavini; Isabel Santana; Simon Ducharme; Chris R Butler; Alexander Gerhard; Johannes Levin; Adrian Danek; Markus Otto; Giovanni B Frisoni; Roberta Ghidoni; Sandro Sorbi; Carolin Heller; Emily G Todd; Martina Bocchetta; David M Cash; Rhian S Convery; Georgia Peakman; Katrina M Moore; Jonathan D Rohrer; Rogier A Kievit; James B Rowe
Journal:  Alzheimers Dement       Date:  2020-12-14       Impact factor: 16.655

7.  GABA and glutamate deficits from frontotemporal lobar degeneration are associated with disinhibition.

Authors:  Alexander G Murley; Matthew A Rouse; P Simon Jones; Rong Ye; Frank H Hezemans; Claire O'Callaghan; Polytimi Frangou; Zoe Kourtzi; Catarina Rua; T Adrian Carpenter; Christopher T Rodgers; James B Rowe
Journal:  Brain       Date:  2020-12-05       Impact factor: 13.501

Review 8.  Parkin beyond Parkinson's Disease-A Functional Meaning of Parkin Downregulation in TDP-43 Proteinopathies.

Authors:  Katarzyna Gaweda-Walerych; Emilia Jadwiga Sitek; Ewa Narożańska; Emanuele Buratti
Journal:  Cells       Date:  2021-12-01       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.